Grizzle William E
J Health Care Poor Underserved. 2019;30(4S):66-78. doi: 10.1353/hpu.2019.0117.
Precision medicine is an approach in which the characteristics of patients as well as their diseases are used to identify optimal therapy; it links researchers, patients, health care providers, and clinical laboratories. In precision medicine, specific molecular characteristics of an untreatable cancer can be targeted by specific molecular-based therapy. Access to high-quality human tissues is necessary to determine many characteristics of patients and their diseases (such as targetable molecules). There are ethical issues in using human tissues in precision medicine, including informed consent and confidentiality, optimal utilization, quality of tissues, and minimization of bias. When human tissues are obtained for patient therapy, the bioresource should be a component certified by Clinical Laboratory Improvement Amendments. For precision medicine to benefit medically underserved populations requires extensive focused research, planning, and resources, some of which are currently unavailable at rural and other sites where care is provided to underserved populations.
精准医学是一种利用患者及其疾病的特征来确定最佳治疗方案的方法;它将研究人员、患者、医疗保健提供者和临床实验室联系起来。在精准医学中,无法治愈的癌症的特定分子特征可以通过特定的基于分子的疗法来靶向治疗。获取高质量的人体组织对于确定患者及其疾病的许多特征(如可靶向分子)是必要的。在精准医学中使用人体组织存在伦理问题,包括知情同意和保密、最佳利用、组织质量以及偏差最小化。当为患者治疗获取人体组织时,生物资源应是经临床实验室改进修正案认证的组成部分。为了使精准医学惠及医疗服务不足的人群,需要进行广泛的针对性研究、规划并投入资源,其中一些资源目前在农村和其他为服务不足人群提供医疗服务的场所无法获得。